Results – 第 6 页 – MicroVibeNews

Canadian Pacific Kansas City Limited 2025 Q4 – Results – Earnings Call Presentation

Canadian Pacific…

South Plains Financial, Inc. 2025 Q4 – Results – Earnings Call Presentation

South Plains Fin…

Epiroc AB (publ) 2025 Q4 – Results – Earnings Call Presentation

Epiroc AB (publ)…

Stabilus SE 2026 Q1 – Results – Earnings Call Presentation

Stabilus SE 2026…

EQT AB (publ) 2025 Q4 – Results – Earnings Call Presentation

EQT AB (publ) 20…

MakeMyTrip Limited 2026 Q3 – Results – Earnings Call Presentation

MakeMyTrip Limit…

London set to test if its IPO market reforms can deliver results

Five years in th…

Apple, Microsoft, Meta To Report Results; Fed's Interest Rate Decision In Focus

Apple, Microsoft…

UltraTech Cement Limited 2026 Q3 – Results – Earnings Call Presentation

UltraTech Cement…

NMAI: Diversified Portfolio At A Hefty Discount, But Mixed Results

NMAI: Diversifie…

Business First Bancshares, Inc. 2025 Q4 – Results – Earnings Call Presentation

Business First B…

Columbia Banking System, Inc. 2025 Q4 – Results – Earnings Call Presentation

Columbia Banking…

VEF AB (publ) 2025 Q4 – Results – Earnings Call Presentation

VEF AB (publ) 20…

Fastenal Company 2025 Q4 – Results – Earnings Call Presentation

Fastenal Company…

Bang & Olufsen A/S 2026 Q2 – Results – Earnings Call Presentation (OTCMKTS:BGOUF) 2026-01-14

This article was…

IEB results: Class of 2025 achieves 98.3% pass rate

A victory for th…

Krystal Biotech, Inc. (KRYS) Discusses Positive Interim Results and Next Steps for Cystic Fibrosis Program KB407 – Slideshow

Krystal Biotech,…

Canadian Imperial Bank of Commerce: Shares Look Pricey On Strong Results

Canadian Imperia…

Acuity Inc. 2026 Q1 – Results – Earnings Call Presentation

Acuity Inc. 2026…

Cal-Maine Foods, Inc. 2026 Q2 – Results – Earnings Call Presentation (NASDAQ:CALM) 2026-01-07

Q2: 2026-01-07 E…

Arrowhead Pharmaceuticals, Inc. (ARWR) Discusses Interim Results From Obesity Candidates and Advances in Treatment Approaches – Slideshow

Arrowhead Pharma…

Neumora Therapeutics, Inc. (NMRA) Discusses Positive Phase 1b Results for NMRA-511 in Alzheimer's Disease Agitation – Slideshow

Neumora Therapeu…